pathogenesis of epilepsy: challenges in animal models

Authors

yow hui yin faculty of pharmacy, university kebangsaan malaysia, kuala lumpur, malaysia

nurulumi ahmad faculty of pharmacy, university kebangsaan malaysia, kuala lumpur, malaysia

mohd makmor-bakry faculty of pharmacy, university kebangsaan malaysia, kuala lumpur, malaysia

abstract

epilepsy is one of the most common chronic disorders affecting individuals of all ages. a greater understanding of pathogenesis in epilepsy will likely provide the basis fundamental for development of new antiepileptic therapies that aim to prevent the epileptogenesis process or modify the progression of epilepsy in addition to treatment of epilepsy symptomatically. therefore, several investigations have embarked on advancing knowledge of the mechanism underlying epileptogenesis, understanding in mechanism of pharmacoresistance and discovering antiepileptogenic or disease-modifying therapy. animal models play a crucial and significant role in providing additional insight into mechanism of epileptogenesis. with the help of these models, epileptogenesis process has been demonstrated to be involved in various molecular and biological pathways or processes. hence, this article will discuss the known and postulated mechanisms of epileptogenesis and challenges in using the animal models.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Pathogenesis of Epilepsy: Challenges in Animal Models

  Epilepsy is one of the most common chronic disorders affecting individuals of all ages. A greater understanding of pathogenesis in epilepsy will likely provide the basis fundamental for development of new antiepileptic therapies that aim to prevent the epileptogenesis process or modify the progression of epilepsy in addition to treatment of epilepsy symptomatically. Therefore, severa...

full text

Pathogenesis of Epilepsy: Challenges in Animal Models

Epilepsy is one of the most common chronic disorders affecting individuals of all ages. A greater understanding of pathogenesis in epilepsy will likely provide the basis fundamental for development of new antiepileptic therapies that aim to prevent the epileptogenesis process or modify the progression of epilepsy in addition to treatment of epilepsy symptomatically. Therefore, several investiga...

full text

P119: Animal Models of Epilepsy: The Impact of some Chemoconvalsants on Animal Models

We summarize some of the most frequenthly used rodent animal models of temporal lobe epileps and the impact of chemoconvulsants on them. Temporal lobe epilepsy is the most common epilepsy in humans in which seizures spread to the neighboring cortiase and hippocampal neuron loss and other neuropathological take place. Temporal lobe epilepsy and the other form of epilepsy cannot acquired in chini...

full text

P 145: A Review of Animal Models of Absence Epilepsy

The most common type of childhood-onset epilepsy syndrome is childhood absence epilepsy (CAE) with well-defined electro clinical features but unknown pathological basis. The incidence of absence epilepsy is about 2 and 8 out of every 100 000 children up to the age of 16, and the prevalence is 2 and 10% of children with any form of epilepsy. Children with CAE suffer from high rate of pretreatmen...

full text

Neurostimulation as a Putative Method for Treatment of Drug-Resistant Epilepsy in Patient and Animal Models of Epilepsy

A patient with epilepsy was shown to have neurobiological, psychological, cognitive, and social issues as a result of recurring seizures, which is regarded to be a chronic brain disease.However, despite numerous drug treatments, approximately, 30–40% of all patients are resistant to antiepileptic drugs. Therefore, newer therapeutic modalities are introduced into clinical practice in which invol...

full text

Challenges in the Treatment of Epilepsy

Epilepsy is one of the most important diseases of nervous system that involves 0.5-1% of the population. In spite of new developments in antiepileptic drugs, between 20-30% of epileptic patients can not be controlled and even those who are controlled with antiepileptic drugs suffer from their adverse events. Epileptic patients have different challenges in relation to the disease and its medicat...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of basic medical sciences

جلد ۱۶، شماره ۱۱، صفحات ۱۱۱۹-۱۱۳۲

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023